Health
newsGP – ‘Important’ study shows gout medication can halt coronary disease progression – RACGP
The major clinical trial found use of low dose colchicine reduces heart attacks and the need for coronary stenting or bypass surgery by 30%.
News
The major clinical trial found use of low dose colchicine reduces heart attacks and the need for coronary stenting or bypass surgery by 30%.
Coronary heart disease is the leading cause of death in Australia.
The international study, published in The New England Journal of Medicine, examined the effect of low dose colchicine in patients with chronic coronary disease who were already taking established treatments.The two-year randomised, controlled, double-blind trial, led by GenesisCare i…
-
Noosa News23 hours agoSurgeon partner of former premier to testify over his patient’s death
-
General21 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business21 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General23 hours agoToo skewed, too gentlemanly | The Spectator Australia